StockData
Harvard Apparatus Regenerative Technology, Inc. logo

Harvard Apparatus Regenerative Technology, Inc. (HRGN) stock

HRGNOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$2.21−0.02 (-0.72%)

Close on Oct 19, 2026Market cap $40.13MP/E –Yield –

Harvard Apparatus Regenerative Technology statistics

38 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
8.76%
3.32%
Shares Change (QoQ)
14.3%
0.20%
Float
14M
37M
Shares Held by Insiders
21.9%
10.5%

MarginsIndustry

Gross Margin
7.47%
55.9%
Operating Margin
-643.0%
-5.12%
Profit Margin
-642.0%
-9.29%
EBITDA Margin
-643.0%
-2.52%

Returns on capitalIndustry

Return on Equity (ROE)
-621.0%
-17.3%
Return on Assets (ROA)
-225.6%
-12.3%
Return on Capital Employed (ROCE)
-1236.8%
-8.13%

Financial positionIndustry

Current Ratio
0.87
2.49
Quick Ratio
0.71
1.53
Interest Coverage
-269.00
-1.63

GrowthIndustry

Revenue Growth (YoY)
35.1%
9.42%

EfficiencyIndustry

Asset Turnover
0.35
0.59
Inventory Turnover
84.45
2.20
Revenue Per Employee
$125.50K
$331.99K
Profits Per Employee
-$805.75K
-$46.47K
Employee Count
8
193

Income statement (TTM)Industry

Revenue
$1.00M
$108.17M
Gross Profit
$75.00K
$62.29M
Operating Income
-$6.46M
-$3.72M
Net Income
-$6.45M
-$6.19M
EBITDA
-$6.46M
-$1.98M
EPS (Diluted)
-$0.37
-$0.11

Balance sheetIndustry

Net Cash (Debt)
$1.85M
$3.95M
Net Cash Per Share
$0.11
$0.26
Equity (Book Value)
$522.00K
$63.80M
Book Value Per Share
$0.03
$3.26
Tangible Book Value
$522.00K
$11.61M
Working Capital
-$345.00K
$57.32M

Cash flow (TTM)Industry

Operating Cash Flow
-$2.79M
-$483.87K

Taxes and interestIndustry

Interest Expense
$24.00K
$5.40M
Income Tax
$0
$1.55M

Scores and fair valueIndustry

Piotroski F-Score
3
5

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodHRGNS&P 500DifferenceHRGN per yearS&P 500 per year
1 month-1.6%+0.6%−2.2 pts
3 months+110.9%+3.4%+107.5 pts
Year to date+20.3%+13.3%+7.0 pts
1 year+21.3%+16.6%+4.7 pts
3 years-48.5%+86.4%−134.9 pts-19.9%+23.1%
5 years-26.2%+81.9%−108.1 pts-5.9%+12.7%
10 years-87.6%+318.9%−406.4 pts-18.8%+15.4%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M HRGN shares were sold short on Oct 30, 2026, up 48.3% from the previous report. At recent volumes it would take 1.0 days to buy them back.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261,013+48.3%2,6301.0
Oct 15, 2026683+9.3%2,3921.0
Sep 30, 2026625-84.0%3,2441.0
Sep 15, 20263,916+571.7%7,0691.0
Aug 31, 20265830.0%4441.3
Aug 14, 2026583-3.3%3,7371.0
Jul 31, 20266030.0%1414.3
Jul 15, 2026603-28.6%7,8381.0
Jun 30, 2026845+53.9%1,1871.0
Jun 15, 2026549+3129.4%1,4681.0
May 29, 202617-71.7%1,3901.0
May 15, 202660-62.7%1,5061.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?